SBPH stock forecast
Our latest prediction for Spring Bank Pharmaceuticals, Inc.'s stock price was made on the Nov. 14, 2019 when the stock price was at 3.13$.
In the short term (2weeks), SBPH's stock price should outperform the market by 4.74%. During that period the price should oscillate between -8.05% and +14.97%.
In the medium term (3months), SBPH's stock price should outperform the market by 2.79%. During that period the price should oscillate between -18.23% and +37.80%.Get email alerts
Create a solid portfolio with SBPH
About Spring Bank Pharmaceuticals, Inc.
Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.50$ per share.
The book value per share is 2.33$
Three months stock forecastNov. 14, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|